Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran Hospitals

New Microbiologica

Volumn 32, Issue 3, 2009, Pages 265-271

  Morovat, Taherikalani ^a   Bahram, Fatolahzadeh ^b   Mohammad, Emaneini ^b   Setareh, Soroush ^a   Mehdi, Feizabadi Mohamad ^a,b  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

A. baumannii; Carbapenem resistant; FIGE patterns

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFOTAXIME; DRUG DERIVATIVE; IMIPENEM; MEROPENEM; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN TAZOBACTAM COMBINATION PRODUCT; PIPERACILLIN-TAZOBACTAM COMBINATION PRODUCT; THIENAMYCIN DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BACTERIAL GENE; CROSS INFECTION; DRUG EFFECT; GENETICS; HOSPITAL; HUMAN; IRAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CEFOTAXIME; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; HOSPITALS; HUMANS; IMIPENEM; IRAN; PENICILLANIC ACID; PIPERACILLIN; THIENAMYCINS;

ACINETOBACTER BAUMANNII;

EID: 70349694413     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. BARGOGNE-BEREZIN E., TOWNER K.J. (1996). Acinetobacter spp as nosocomial pathogens: Microbiological, clinical and epidemiological features. Clin. Microbiol. Rev. 9, 148-165.
2. BIENDO M., LAURANS G., LEFEBVRE J.F., DAOUDI F, EB F. (1999). Epidemiological study of an Acinetobacter baumannii outbreak by using a combination of an- tibiotyping and ribotyping. J. Clin. Microbiol. 37, 2170-2175.
3. BOUVET P.J.M., GRIMONT P.A.D. (1986). Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int. J. Syst. Bacteriol. 36, 228- 240.
4. Bou G., Cervero G., Dominguez M.A., Quereda C, Martinez-Beltran J. (2000). Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapen- em-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J. Clin. Microbiol. 38, 3299-3305.
5. Clinical and Laboratory Standards Institute. (2006). Performance standards for antimicrobial susceptibility testing. Approved standard. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa.
6. COELHOA J., WOODFORDA N., TURTON J.F, LlVERMOREA D.M. (2004). Multiresistant acinetobacter in the UK: how big a threat? J Hosp. Infect. 58, 167-169.
7. DALLA-COSTA L.M., COELHO J.M., SOUZA H.A., CASTRO M.E., STIER C.J., BRAGAGNOLO K.L., REA-NETO A., PENTEADO-FLHO S.R., LIVERMORE D.M., WOODFORD N. (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41, 3403-3406.
8. DA SILVA G.J., QUINTEIRA S., BERTOLO E., SOUSA J.C., GALLEGO L., DUARTE A., PEIXE L., PORTUGESE RESISTANCE STUDY GROUP. (2004). Long-term dissemination of an OXA-40 carbapenemase-produc- ing Acinetobacter baumannii clone in the Iberian Peninsula. J. Antimicrob. Chemother. 54, 255-258.
9. ESER O.K., ERGIN A., TUNCKANAT F, HASSCELIK G. (2008). In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp. New Microbiol. 31, 535-542.
10. FLAHERTY J.P., WEINSTEIN R.A. (1996). Nosocomial infections caused by antibiotic- resistant organisms in the intensive-care unit. Infect. Control. Hosp. Epidemiol. 17, 236-248.
11. GARCIA-ARATA M.I., GERNER-SMIDT P., LOPEZ-BREA M. (1997). Epidemiological study of Acinetobacter species isolated from an intensive care unit. A.P.M.I.S. 105, 131-138.
12. HENWOOD C.J., GATWARD T., WARNER M., JAMES D., SOCKDALE M.W, SPENCE R.P., TOWNER K.J., LIVERMORE D.M., WOODFORD N. (2002). Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J. Antimicrob. Chemother. 49, 479-487.
13. HERITIER C, DUBOUIX A., POIREL L., MARTY N., NORDMANN P. (2005). A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem- hydrolysing oxacillinase OXA-58. J. Antimicrob. Chemother. 55,115-118.
14. JEON B.C., JEONG S.H., BAE I.K., KWON S.B., LEE K., YOUNG D., LEE J.H., SONG J.S, LEE S.H. (2005). Investigation of a nosocomial outbreak of imipen- em-resistant Acinetobacter baumannii producing the OXA-23 betalactamase in Korea. J. Clin. Microbiol. 43, 2241-2245. (Pubitemid 40656234)
15. LOPEZ-OTSOA R, GALLEGO L., TOWNER K.J., TYSALL L., WOODFORD N., LIVERMORE D.M. (2002) Endemic carbapenem resistance associated with OXA-40 car- bapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J. Clin. Microbiol 40, 4741- 4743.
16. LYYTIKAINEN O., KOLJLG S., HARMA M., VUOPIO-VARKILA J. (1995). Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem. J. Hosp. Infect. 31,41-54.
17. LING J.M., WISE R., WOO T.H., CHENG A.F. (1996). Investigation of the epidemiology of hospital isolates of Acinetobacter anitratus by two molecular methods. J. Hosp. Infect. 32, 29-38.
18. MARQUE S., POIREL L., HERITIER C, BRISSE S., BLASCO M.D., FILIP R., COMAN G., NAAS T., NORDMANN P. (2005). Regional occurrence of plasmidmediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J. Clin. Microbiol. 43, 4885-4888.
19. MULIN B., TALON D., VIEL J.F., VINC C, LEPRAT R., THOUVEREZ M., MICHEL-BRIAND Y. (1995) Risk factors for nosocomial colonization with multiresis- tant Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 14, 569-576.
20. MARCOS M.A., ABDALLA S., PEDRAZA F, ANDREU A., FERNANDEZ F, GOMEZ-LUS R., JIMENEZ DE ANTA M.T., VILA J. (1994) Epidemiological markers of Acinetobacter baumannii clinical isolates from Spinal Cord Injury Unit. J. Hosp. Infect. 28, 39-48.
21. NAAS T., LEVY M., HIRSCHAUER C, MARCHANDIN H., NORDMANN P. (2005). Outbreak of carbapenem-re- sistant Acinetobacter baumannii producing the car- bapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J. Clin. Microbiol. 43, 4826-4829.
22. RATTO P., SORDELLI D.O., ABELEIRA E., TORRERO M., CATALANO M. (1995) Molecular typing of Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolates from endemic and epidemic nosocomial infections. Epidemiol. Infect. 114, 123-132.
23. SADER H.S., MEMDES C.F., PIGNATARIA A.C., PFALLER M.A. (1996). Use of macrorescriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in Sao Paulo, Brazil. Clin. Infect. Dis. 23, 631-634.
24. xA-typeacute; carbapenemase genes among burn patients in Tehran, Iran. Saudi. Med. J. 29, 623-624.
25. TURTON J.F., KAUFMANN M.E, WARNER M., COELHO J., DIJKSHOORN L., VAN DER REDDEN T., Pnr T.L. (2004). A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J. Hosp. Infect. 58, 170-179.
26. TURTON J.F., WOODFORD N., GLOVER J., YARDE S., KAUFMANN M.E., PITT T.L. (2006). Identification of Acinetobacter baumannii by detection of the WaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974-2976.
27. TURTON J.F., WARD M.E., WOOD N., KAUFMANN M.E.E., PIKE R., LIVERMORE D.M., PITT T.L. (2006). The role of ISAbal in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258, 72-77.
28. TENOVER F.C, ARBEIT R.D., GOERING R.V., MICKELSEN P.A., MURRAY B.E., PERSING D.H., SWAMINATHAN B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial isolate typing. J. Clin. Microbiol. 33, 2233-2239.
29. WROBLEWSKS M.M., DIJKSHOORN L., MARCHEL H., VAN DEN BARSEAAR M., SWOBODA-KOPEC E., VAN DEN BROEK P.J., LUCZAK M. (2004). Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients. J. Hosp. Infect. 57, 300- 307.
30. WOODFORD N., ELLINGTON M.J., COELHO J.M., TURTON J.F., WARD M.E., BROWN S., AMYES S.G., LIVERMORE D.M. (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents. 27, 351-353.
31. WOFFORD D.L.S, OLSEN G.J., WADDELL P.J., HiLLis D.M. (1996). Molecular Systematics. Massachusetts, Sinauer Associates, Inc, Sunderland, USA.